Production (Stage)
Opus Genetics, Inc.
IRD
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.37M | 4.30M | 3.87M | 1.11M | 1.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.37M | 4.30M | 3.87M | 1.11M | 1.71M |
| Cost of Revenue | 7.89M | 7.78M | 8.75M | 6.08M | 4.74M |
| Gross Profit | -3.52M | -3.48M | -4.88M | -4.97M | -3.03M |
| SG&A Expenses | 6.41M | 7.27M | 2.90M | 3.36M | 4.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.30M | 14.33M | 11.88M | 9.44M | 9.42M |
| Operating Income | -9.93M | -10.03M | -8.01M | -8.33M | -7.71M |
| Income Before Tax | -8.19M | -35.14M | -7.53M | -7.77M | -7.11M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.19M | -35.14M | -7.53M | -7.77M | -7.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.19M | -35.14M | -7.53M | -7.77M | -7.11M |
| EBIT | -9.93M | -10.03M | -8.01M | -8.33M | -7.71M |
| EBITDA | -9.92M | -10.03M | -8.01M | -8.33M | -7.71M |
| EPS Basic | -0.24 | -1.16 | -0.29 | -0.30 | -0.29 |
| Normalized Basic EPS | -0.15 | -0.15 | -0.18 | -0.19 | -0.18 |
| EPS Diluted | -0.24 | -1.16 | -0.29 | -0.30 | -0.29 |
| Normalized Diluted EPS | -0.15 | -0.15 | -0.18 | -0.19 | -0.18 |
| Average Basic Shares Outstanding | 33.88M | 30.36M | 26.15M | 25.83M | 24.52M |
| Average Diluted Shares Outstanding | 33.88M | 30.36M | 26.15M | 25.83M | 24.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |